The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.
| Date |
Communication |
Topic |
|
22/08/2025
|
Dear Healthcare Professional Letter
|
Topiramate-Actavis: New restrictions to prevent exposure during pregnancy (PDF, 7 pages, 848 KB)
|
|
14/08/2025
|
Dear Healthcare Professional Letter
|
Vancomycin (as hydrochloride) – approval for European batch to mitigate short-term gap in supply (PDF, 1 page, 114 KB)
|
|
12/08/2025
|
Dear Healthcare Professional Letter
|
Lenalidomide Viatris (lenalidomide) capsules – alternative registered foils (PDF, 2 pages, 306 KB)
|
|
04/08/2025
|
Dear Healthcare Professional Letter
|
Ocrevus (ocrelizumab): liver injury (without findings of viral hepatitis) (PDF, 3 pages, 219 KB)
|
|
31/07/2025
|
Monitoring
|
Update - Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, obinutuzumab, ofatumumab) and the possible risk of pyoderma gangrenosum
|
|
22/07/2025
|
Alert
|
Warning: advertisements claiming Medsafe approval or bearing the Medsafe logo are scams
|
|
21/07/2025
|
Dear Healthcare Professional Letter
|
CellCept (myophenolate mofetil): New important identified risk: anaphylactic reaction (PDF, 3 pages, 135 KB)
|
|
14/07/2025
|
Dear Healthcare Professional Letter
|
Lenalidomide Viatris capsules (lenalidomide): labelling exemption for alternative registered foils (PDF, 2 pages, 543 KB)
|
|
30/06/2025
|
Consumer information leaflet
|
Reporting side effects of medicines and vaccines (PDF, 1 page, 166 KB)
|
|
24/06/2025
|
Consultation outcome
|
Outcome of the consultation on the proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
|
|
13/06/2025
|
Dear Healthcare Professional Letter
|
Risperdal (risperidone): Accidental overdoses in children and adolescents treated with risperidone 1mg/ml oral solution following administration errors (PDF, 8 pages, 308 KB)
|
|
30/05/2025
|
Alert
|
Stop using Euky Bear Warm Steam Vaporiser – model number EBSV2013
|
|
30/05/2025
|
Dear Healthcare Professional Letter
|
Ventolin (salbutamol (as sulfate) aerosol inhaler) - reinforcing information regarding number of prescribed doses available (PDF, 2 pages, 200 KB)
|
|
22/05/2025
|
Dear Healthcare Professional Letter
|
Estradiol Transdermal Patches (Mylan) granted full consent; US packs will continue to be supplied in the short-term (PDF, 3 pages, 352 KB)
|
|
22/05/2025
|
Dear Healthcare Professional Letter
|
Zyprexa IM (olanzapine) 10mg powder for injection: Temporary supply of overseas product (PDF, 2 pages, 226 KB)
|
